Skip to content
★ Sign in to follow
BW

Björn Westberg

SynAct Pharma AB
Insider activity · 24 months2 buys0 salesCumulative net flow
Total declarations
7
Company
1
▲ Purchases (4 ops.)
€35k
▼ Sales (0 ops.)
—

Latest filing published 25 Jun 2025 for SynAct Pharma AB, €3,865.

Filing timeline

BuySale
Björn Westberg

Insider track record

Disclosed buys
4
Disclosed sells
0
Signal history

Closed purchases

Market purchases
4

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Björn Westberg: trading record in brief

Björn Westberg is a declared insider of SynAct Pharma AB, with filings sourced from Finansinspektionen. Over a trading history stretching from 1 June 2023 to 25 June 2025, the count stands at 7 filings.

On the market, this insider has only ever bought: 4 purchases, €35k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 2 share grants. So far in 2025, the count stands at 3 purchases and no sales.

The median purchase comes to €8,771. 2 out of 4 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

The record was last updated on 25 June 2025 with an open-market purchase (€3,865) in SynAct Pharma AB. The median gap between a trade and its publication by Finansinspektionen is 3 days. The legal deadline for notifying a trade is three business days (MAR article 19). This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.

Companies and markets linked to Björn Westberg

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations7 total
  • ▲
    Ekonomichef/finanschef/finansdirektörExecutivesSynAct Pharma AB
    42,749 SEK38FI-SE
    2,440 shares@ SEK 17.528.8% of flowAktieISIN SE0008241491FI:csv-5891118c0baf9acb921f
    Canonical exit: 23 Sept 2025 (T+90)
  • ▲
    Ekonomichef/finanschef/finansdirektörExecutivesSynAct Pharma AB
    99,994 SEK33FI-SE
    11,560 shares@ SEK 8.6519.7% of flowAktieISIN SE0008241491FI:csv-a24c9a94c9c07643c23e
    Canonical exit: 30 Mar 2025 (T+90)
  • ▲
    Ekonomichef/finanschef/finansdirektörExecutivesSynAct Pharma AB
    99,994 SEK21FI-SE
    11,560 shares@ SEK 8.6520.0% of flowAktieISIN SE0008241491FI:csv-3f06d91329bb3463a09b
    Canonical exit: 29 Apr 2024 (T+90)
  • ◆
    Ekonomichef/finanschef/finansdirektörExecutivesSynAct Pharma AB
    0FI-SE
    516,205 shares0OptionISIN SE0008241491FI:csv-8e060e43ecac70936a70
  • ●
    Ekonomichef/finanschef/finansdirektörExecutivesSynAct Pharma AB
    103,200 SEK23FI-SE
    12,000 shares@ SEK 8.6039.0% of flowAktieISIN SE0008241491FI:csv-c4461280f9277e649698
  • ▲
    Ekonomichef/finanschef/finansdirektörExecutivesSynAct Pharma AB
    164,900 SEK25FI-SE
    10,000 shares@ SEK 16.4961.0% of flowAktieISIN SE0008241491FI:csv-fae217b21663250d9dea
    Canonical exit: 4 Dec 2023 (T+90)
  • ◆
    Ekonomichef/finanschef/finansdirektörExecutivesSynAct Pharma AB
    0FI-SE
    65,000 shares0OptionFI:csv-e4f61a5243cee848a3cc

7 of 7 declarations